FLNA

NASDAQ 已收盘

Filana Therapeutics

0.64 USD
▲+0.08+14.52%
盘后 0.63 -2.12%
2026-11-20
市值
$32.24M
市盈率
—
EPS
-0.87
股息率
—
52 周区间
0.39 – 3.45
成交量
1.33M
Beta
-0.45
目标价
6.50
52W 低 0.3952W 高 3.45
价格走势

公司简介

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer’s disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The...